Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 18616 | 28.25 |
09:34 ET | 2288 | 28.23 |
09:36 ET | 2750 | 28.23 |
09:38 ET | 3467 | 28.23 |
09:39 ET | 104086 | 28.23 |
09:41 ET | 8265 | 28.24 |
09:43 ET | 4246 | 28.27 |
09:45 ET | 20969 | 28.29 |
09:48 ET | 3971 | 28.25 |
09:50 ET | 9829 | 28.24 |
09:52 ET | 2151 | 28.28 |
09:54 ET | 2800 | 28.25 |
09:56 ET | 9011 | 28.15 |
09:57 ET | 23205 | 28.19 |
09:59 ET | 200 | 28.19 |
10:01 ET | 5474 | 28.16 |
10:03 ET | 2970 | 28.135 |
10:06 ET | 1435 | 28.15 |
10:08 ET | 10932 | 28.135 |
10:10 ET | 3761 | 28.15 |
10:12 ET | 1047 | 28.17 |
10:14 ET | 2864 | 28.185 |
10:15 ET | 3161 | 28.135 |
10:17 ET | 1874 | 28.12 |
10:19 ET | 700 | 28.12 |
10:21 ET | 500 | 28.115 |
10:24 ET | 1379 | 28.135 |
10:26 ET | 2547 | 28.125 |
10:28 ET | 6287 | 28.145 |
10:30 ET | 500 | 28.155 |
10:32 ET | 200 | 28.179 |
10:33 ET | 2497 | 28.1725 |
10:35 ET | 7717 | 28.225 |
10:37 ET | 2549 | 28.285 |
10:39 ET | 4045 | 28.29 |
10:42 ET | 3516 | 28.26 |
10:44 ET | 2042 | 28.265 |
10:46 ET | 674 | 28.27 |
10:48 ET | 1472 | 28.27 |
10:50 ET | 2828 | 28.275 |
10:51 ET | 2985 | 28.26 |
10:53 ET | 1696 | 28.24 |
10:55 ET | 2777 | 28.265 |
10:57 ET | 7367 | 28.275 |
11:00 ET | 1200 | 28.285 |
11:02 ET | 2033 | 28.32 |
11:04 ET | 12052 | 28.3 |
11:06 ET | 112816 | 28.27 |
11:08 ET | 10325 | 28.265 |
11:09 ET | 3653 | 28.27 |
11:11 ET | 3800 | 28.3 |
11:13 ET | 3288 | 28.3 |
11:15 ET | 3853 | 28.31 |
11:18 ET | 4537 | 28.34 |
11:20 ET | 3374 | 28.36 |
11:22 ET | 2466 | 28.32 |
11:24 ET | 1542 | 28.325 |
11:26 ET | 4409 | 28.34 |
11:27 ET | 1818 | 28.34 |
11:29 ET | 3017 | 28.34 |
11:31 ET | 1300 | 28.35 |
11:33 ET | 2340 | 28.345 |
11:36 ET | 43965 | 28.37 |
11:38 ET | 2256 | 28.36 |
11:40 ET | 7128 | 28.315 |
11:42 ET | 3191 | 28.31 |
11:44 ET | 3413 | 28.31 |
11:45 ET | 2326 | 28.315 |
11:47 ET | 931 | 28.305 |
11:49 ET | 5095 | 28.28 |
11:51 ET | 301 | 28.28 |
11:54 ET | 2870 | 28.2954 |
11:56 ET | 4321 | 28.3363 |
11:58 ET | 719 | 28.33 |
12:00 ET | 879 | 28.345 |
12:02 ET | 11821 | 28.325 |
12:03 ET | 2107 | 28.32 |
12:05 ET | 6169 | 28.295 |
12:07 ET | 2419 | 28.29 |
12:09 ET | 1201 | 28.31 |
12:12 ET | 6906 | 28.31 |
12:14 ET | 2871 | 28.3 |
12:16 ET | 3222 | 28.305 |
12:18 ET | 5777 | 28.315 |
12:20 ET | 1607 | 28.305 |
12:21 ET | 1300 | 28.305 |
12:23 ET | 15607 | 28.34 |
12:25 ET | 2467 | 28.34 |
12:27 ET | 3250 | 28.34 |
12:30 ET | 5152 | 28.295 |
12:32 ET | 2194 | 28.265 |
12:34 ET | 5573 | 28.28 |
12:36 ET | 900 | 28.275 |
12:38 ET | 5054 | 28.295 |
12:39 ET | 300 | 28.2945 |
12:41 ET | 3965 | 28.295 |
12:43 ET | 3122 | 28.305 |
12:45 ET | 5027 | 28.29 |
12:48 ET | 6497 | 28.3 |
12:50 ET | 3420 | 28.305 |
12:54 ET | 3400 | 28.32 |
12:56 ET | 3289 | 28.315 |
12:57 ET | 853 | 28.32 |
12:59 ET | 4503 | 28.315 |
01:01 ET | 2663 | 28.295 |
01:03 ET | 4008 | 28.28 |
01:06 ET | 5335 | 28.29 |
01:08 ET | 6134 | 28.315 |
01:10 ET | 4780 | 28.3034 |
01:12 ET | 154 | 28.305 |
01:14 ET | 3841 | 28.315 |
01:15 ET | 3882 | 28.295 |
01:17 ET | 3126 | 28.2958 |
01:19 ET | 5254 | 28.31 |
01:21 ET | 492 | 28.3012 |
01:24 ET | 3624 | 28.3 |
01:26 ET | 287 | 28.3 |
01:28 ET | 4288 | 28.31 |
01:30 ET | 4391 | 28.295 |
01:32 ET | 1946 | 28.305 |
01:33 ET | 5561 | 28.305 |
01:35 ET | 2102 | 28.29 |
01:37 ET | 2854 | 28.27 |
01:39 ET | 12414 | 28.235 |
01:42 ET | 1783 | 28.225 |
01:44 ET | 4498 | 28.23 |
01:46 ET | 200 | 28.2301 |
01:48 ET | 3049 | 28.2499 |
01:50 ET | 3129 | 28.23 |
01:51 ET | 2518 | 28.235 |
01:53 ET | 4131 | 28.26 |
01:55 ET | 3715 | 28.25 |
01:57 ET | 6226 | 28.255 |
02:00 ET | 1163 | 28.27 |
02:02 ET | 2612 | 28.255 |
02:04 ET | 1300 | 28.265 |
02:06 ET | 2458 | 28.25 |
02:08 ET | 543 | 28.2505 |
02:09 ET | 7805 | 28.23 |
02:11 ET | 2291 | 28.245 |
02:13 ET | 900 | 28.24 |
02:15 ET | 454 | 28.245 |
02:18 ET | 8265 | 28.225 |
02:20 ET | 3307 | 28.22 |
02:22 ET | 3119 | 28.21 |
02:24 ET | 2019 | 28.215 |
02:26 ET | 1203 | 28.22 |
02:27 ET | 571 | 28.225 |
02:29 ET | 1100 | 28.245 |
02:31 ET | 500 | 28.25 |
02:33 ET | 12021 | 28.21 |
02:36 ET | 1297 | 28.205 |
02:38 ET | 585 | 28.21 |
02:40 ET | 300 | 28.205 |
02:42 ET | 4900 | 28.21 |
02:44 ET | 4419 | 28.2 |
02:45 ET | 631 | 28.195 |
02:47 ET | 317 | 28.2 |
02:49 ET | 2146 | 28.205 |
02:51 ET | 697 | 28.21 |
02:54 ET | 4609 | 28.235 |
02:56 ET | 9918 | 28.23 |
02:58 ET | 563 | 28.23 |
03:00 ET | 900 | 28.24 |
03:02 ET | 5858 | 28.23 |
03:03 ET | 1663 | 28.225 |
03:05 ET | 2422 | 28.235 |
03:07 ET | 6787 | 28.22 |
03:09 ET | 6603 | 28.245 |
03:12 ET | 1863 | 28.245 |
03:14 ET | 566 | 28.245 |
03:16 ET | 11189 | 28.225 |
03:18 ET | 16587 | 28.195 |
03:20 ET | 2379 | 28.185 |
03:21 ET | 8942 | 28.175 |
03:23 ET | 1568 | 28.175 |
03:25 ET | 2060 | 28.165 |
03:27 ET | 918 | 28.165 |
03:30 ET | 12632 | 28.125 |
03:32 ET | 5607 | 28.135 |
03:34 ET | 1559 | 28.14 |
03:36 ET | 8414 | 28.115 |
03:38 ET | 7677 | 28.145 |
03:39 ET | 2199 | 28.14 |
03:41 ET | 3605 | 28.155 |
03:43 ET | 6885 | 28.145 |
03:45 ET | 8741 | 28.135 |
03:48 ET | 15026 | 28.195 |
03:50 ET | 8487 | 28.19 |
03:52 ET | 4829 | 28.205 |
03:54 ET | 38712 | 28.165 |
03:56 ET | 34551 | 28.205 |
03:57 ET | 35756 | 28.22 |
03:59 ET | 33803 | 28.21 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.8B | 15.8x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -12.2x | --- |
Catalent Inc | 10.0B | -8.6x | --- |
Jazz Pharmaceuticals PLC | 7.1B | 22.6x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.5B | -40.5x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.8B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.98% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.8x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 14.1x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.